Related Experiment Videos
Telomere reduction in endometrial adenocarcinoma
1Department of Obstetrics and Gynecology, Albert Einstein Medical Center, Philadelphia, Pennsylvania.
American Journal of Obstetrics and Gynecology
|December 1, 1992
Summary
Endometrial tumors show reduced telomere sequences compared to normal tissue. This telomere shortening may play a role in the development and progression of endometrial cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Genomic instability is a hallmark of cancer.
- Telomeres, protective caps on chromosomes, shorten with each cell division.
- Telomere loss is implicated in the genomic instability observed in solid tumors.
Purpose of the Study:
- To investigate the role of telomere length in endometrial adenocarcinoma.
- To compare telomere repeat sequences in cancerous endometrial tissue versus adjacent normal tissue.
Main Methods:
- DNA was extracted from 11 patient tumor and normal endometrial tissues and 5 endometrial carcinoma cell lines.
- Relative telomere repeat sequence number was quantified using hybridization to a human telomeric repeat probe.
- Hybridization signals were measured using autoradiography and a beta-particle detection system.
Main Results:
- Ten out of eleven endometrial adenocarcinoma cases exhibited reduced telomere repeat sequences in tumor tissue compared to normal tissue.
- Telomere reduction was also observed in the studied endometrial carcinoma cell lines.
Conclusions:
- Telomere sequence reduction is a characteristic genetic feature of many endometrial tumors.
- This telomere shortening may contribute to the initiation and advancement of endometrial carcinoma.
- Alternatively, telomere reduction could be a consequence of the cancer development process.